Bladder cancer decisions — 2025
257 indexed Board decisions in 2025.
Badges describe the whole decision, not the outcome for every condition listed. An appeal can grant one issue and deny or remand another. Check the original decision for each issue; these outcomes do not predict your claim.
- Whole decision: DeniedDecember 2025
The Board denied the veteran's claims for an increased rating for coronary artery disease, service connection for bladder cancer and chronic obstructive pulmonary disease.
- Whole decision: GrantedDecember 2025
The Veteran is entitled to an effective date of March 13, 2012, for his claim of entitlement to service connection for residuals of bladder cancer.
- Whole decision: GrantedDecember 2025
The Board granted a 40 percent rating for voiding dysfunction, residuals of bladder cancer, effective March 19, 2023.
- Whole decision: DeniedDecember 2025
The Board denied increased ratings for bladder cancer, heart disease, PTSD, back condition, and sciatic nerve radiculopathy.
- Whole decision: Partly grantedDecember 2025
The Veteran's service-connected bladder cancer residuals were granted a 100 percent rating from April 29, 2016, to May 1, 2018; a 20 percent rating from August 11, 2020, to June 19, 2023; and a 60 percent rating from June 20, 2023, to January 25, 2024.
- Whole decision: DeniedDecember 2025
The Board denied service connection for various conditions, including right knee condition, unexplained aching bones and joints, right lower extremity radiculopathy, right hip osteoarthritis, left foot trace edema, right foot trace edema, left hand degenerative arthritis, right hand degenerative arthritis, large submandibular growth on left side of neck, pyoderma gangrenosum of bilateral lower extremities, and bladder cancer.
- Whole decision: GrantedNovember 2025
The Board granted an earlier effective date of February 27, 2017, for the award of special monthly compensation (SMC) based on loss of use of creative organ.
- Whole decision: DeniedNovember 2025
The Board denied the veteran's claims for an earlier effective date, a separate rating, and increased ratings for his service-connected conditions.
- Whole decision: DeniedNovember 2025
The Board denied service connection for multiple conditions, including radical cystectomy residuals with colonic pouch, ventral hernia, hypertension, and others, as the evidence did not corroborate the Veteran's reported exposure to Agent Orange or asbestos during service.
- Whole decision: GrantedNovember 2025
The Veteran was granted a rating of 20 percent for bladder cancer residuals manifesting as urinary frequency from July 14, 2016, to November 14, 2021, and a rating of 30 percent for renal dysfunction beginning November 14, 2021.
- Whole decision: Remanded (sent back)November 2025
The Board remands the claims for service connection for coronary artery disease, bladder cancer, hypertension, and prostate cancer to correct a duty to assist error regarding the Veteran's asserted in-service exposure to herbicide agents based on the information included in the claims file.
- Whole decision: GrantedNovember 2025
The Board granted service connection for bladder cancer based on the Veteran's exposure to fine particulate matter during his active duty in Saudi Arabia after August 2, 1990.
- Whole decision: DismissedNovember 2025
The Veteran withdrew his appeal for service connection of bladder cancer before the Board issued a decision.
- Whole decision: Partly grantedNovember 2025
The Veteran's claims for an earlier effective date for the grants of service connection for bladder cancer and hypothyroidism are granted, while the claim for a TDIU is denied. A 30 percent disability rating was assigned for hypothyroidism.
- Whole decision: GrantedPACT Act · November 2025
The Board granted service connection for bladder cancer and type II diabetes mellitus due to herbicide exposure, effective from the date of claim.
- Whole decision: Partly grantedNovember 2025
The Board granted service connection for bladder cancer due to herbicide exposure and hypertension, but remanded the claims for erectile dysfunction, anxiety disorder, and depression disorder.
- Whole decision: Partly grantedNovember 2025
The Board granted a 30 percent initial rating for COPD from April 16, 2020, and denied an increased rating in excess of 60 percent for bladder cancer. The Veteran was also granted a total disability rating based on individual unemployability (TDIU) from the same date.
- Whole decision: DeniedNovember 2025
The Board denied the claimant's eligibility for direct payment of attorney fees based on past-due benefits awarded from the grants of service connection for bladder cancer and special monthly compensation.
- Whole decision: DeniedNovember 2025
The Board denied service connection for both bladder cancer and kidney stones, finding no evidence linking these conditions to the Veteran's military service.
- Whole decision: DeniedNovember 2025
The Board denied service connection for bladder cancer as there was no evidence of exposure to herbicides, radiation, or burn pits during the veteran's service. The disease did not manifest in service and is not otherwise related to an in-service event, injury, or disease.
← Back to Bladder cancer overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.